Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × ponatinib × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Blast Crisis 5 Leukemia, Myeloid, Accelerated Phase 4 Leukemia 4 Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Acute 2 Piebaldism 1 Neoplasms by Histologic Type 1 Myeloproliferative Disorders 1 Lymphoma 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Bone Marrow Diseases 1

Interventions

Cyclophosphamide 31 Doxorubicin 20 pembrolizumab 19 fludarabine 18 Nivolumab 18 fludarabine phosphate 16 Vinblastine 16 Dacarbazine 16 Brentuximab Vedotin 16 Whole-Body Irradiation 15 Mycophenolic Acid 15 Etoposide 13 Melphalan 12 Filgrastim 11 Tacrolimus 10 Gemcitabine 10 Bleomycin 9 Rituximab 8 Radiotherapy 8 Granulocyte Colony-Stimulating Factor 8 Vincristine 7 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 pegfilgrastim 6 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Bendamustine Hydrochloride 6 Thiotepa 5 Specimen Handling 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡